PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.84%
Some net income increase while AVGO is negative at -9.78%. John Neff would see a short-term edge over the struggling competitor.
13.44%
Some D&A expansion while AVGO is negative at -0.37%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
42.53%
Well above AVGO's 17.96% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-100.00%
Negative yoy SBC while AVGO is 38.36%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
100.69%
Well above AVGO's 18.76% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
47.52%
AR growth while AVGO is negative at -9.46%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
21.88%
Inventory growth well above AVGO's 26.35%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
176.03%
A yoy AP increase while AVGO is negative at -354.36%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
137.09%
Growth well above AVGO's 68.61%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
318.64%
Some yoy increase while AVGO is negative at -33.99%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
119.08%
Operating cash flow growth above 1.5x AVGO's 7.23%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-16.21%
Both yoy lines negative, with AVGO at -44.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-84.23%
Negative yoy purchasing while AVGO stands at 45.71%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-98.97%
Both yoy lines negative, with AVGO at -176.92%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-206.54%
We reduce yoy invests while AVGO stands at 23.56%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
259.87%
Debt repayment above 1.5x AVGO's 89.41%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
-2.54%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
53.75%
We have some buyback growth while AVGO is negative at -107.07%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.